U.S. approves GSK's purchase of Novartis vaccine business: companies

WASHINGTON (Reuters) - GlaxoSmithKline won U.S. antitrust approval to buy Novartis AG's vaccine business, with the exception of influenza vaccines, the two companies said on Wednesday. The deal is part of a three-way transaction unveiled in April, which includes Britain's GSK buying the vaccines business of Novartis, the Swiss company purchasing GSK's cancer drugs, and the two groups tying up in consumer healthcare. The U.S. ...

via Health News Headlines - Yahoo News http://ift.tt/1xHauSy